Skip to main content

Table 3 Mean estimated within-person changes (with 95% confidence intervals) associated with use of oyster mushrooms*

From: Antihyperlipidemic effects of Pleurotus ostreatus (oyster mushrooms) in HIV-infected individuals taking antiretroviral therapy

  Day 14
mean change
(95% CI)
Day 28
mean change
(95% CI)
Day 42
mean change
(95% CI)
Day 56
mean change
(95% CI)
Total Cholesterol -9.72
(-20.66, 1.23)
-12.99
(-26.89, 0.91)
4.33
(-11.39, 20.04)
-1.70
(-17.41, 14.02)
Non-HDL -8.06
(-18.72, 2.60)
-10.89
(-23.51, 1.73)
2.06
(-13.24, 17.35)
-4.25
(-19.06, 10.56)
VLDL 2.80
(-4.47, 10.06)
3.47
(-4.08, 11.03)
5.86
(-3.45, 15.16)
-4.07
(-10.73, 2.59)
LDL -8.73
(-20.41, 2.96)
-5.10
(-17.19, 6.99)
2.01
(-12.23, 16.25)
6.89
(-9.29, 23.07)
HDL -1.65
(-3.54, 0.23)
-2.10
(-5.05, 0.85)
2.27
(-0.70, 5.24)
2.55
(-0.07, 5.17)
Triglycerides -22.79
(-102.56, 56.98)
-16.64
(-86.78, 53.50)
-13.64
(-100.67, 73.40)
-62.98
(-120.92, -5.05)
Glucose 0.23
(-5.68, 6.13)
1.90
(-1.77, 5.57)
4.59
(-1.51, 10.68)
-0.12
(-6.25, 6.01)
AST -1.37
(-5.60, 2.86)
-4.62
(-9.65, 0.41)
-2.20
(-7.34, 2.95)
-2.09
(-7.43, 3.26)
ALT -1.31
(-4.22, 1.62)
-3.33
(-6.85, 0.18)
1.56
(-3.29, 6.41)
0.36
(-4.44, 5.15)
  1. * Statistically significant (p < 0.05) changes noted in bold.